Polymerase Chain Reaction Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Polymerase Chain Reaction Market is Segmented by Product (Instruments, Reagents and Consumables, and Software), Application (Clinical Diagnostics, Life Science Research, Industrial Applications, and Other Applications), End User (Academic Institutes, Clinical Diagnostics Labs and Hospitals, Pharmaceutical and Biotechnology Industries, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

Market Snapshot

Polymerase Chain Reaction Market Summary
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: >7.8 %
Polymerase Chain Reaction Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Polymerase Chain Reaction Market is expected to register a CAGR of more than 7.8% during the forecast period.

The COVID-19 pandemic has significantly impacted the polymerase chain reaction market growth. There is a positive impact on the PCR market due to the increasing demand in the clinical diagnostic segment of the market. As the authorities have not recommended the viral culture tests, almost all the diagnostic tests use RT-PCR to test the population who have symptoms of COVID-19 and are advised by healthcare professionals to undergo a diagnostic test. Most pharmaceutical and biotechnological companies are focusing on the research and development departments on identifying new molecules or leads for the treatment of COVID-19.​ For instance, in May 2021, Cipla Limited launched ‘ViraGen’, a polymerase chain reaction (Covid-19 RT-PCR) test for Covid-19 in India in partnership with Ubio Biotechnology Systems Pvt. Ltd.

The major factors driving the growth of the polymerase chain reaction market include the increasing application in clinical diagnostics, rising demand for personalized and precision medicine, and technological advancements and applications in drug development.

Rising demand for personalized and precision medicine is a major factor driving the market growth. Personalized medicine, which aims to provide tailor-made therapies to individual patients, depending on the molecular basis of disease, became popular over recent years. The aging global population and the rising prevalence of chronic disease are putting unrelenting pressure on the healthcare system's capacity and financial viability across the world. According to the World Population Prospects: the 2019 Revision, one in every six people will be over 65 years of age by 2050. The rising demand for personalized medicine has thus created tremendous opportunities in the field of genetic medicine. Also, to facilitate personalized medicine, it is crucial to develop precise and reproducible means of gaining molecular information about the underlying disease, which can be used to guide clinical decision-making. PCR techniques are, therefore, being increasingly utilized in such screening methods.

Additionally, technological advancements in molecular biology, life sciences, and biotechnology have brought a paradigm shift in drug discovery, personalized medicines, forensic sciences, and clinical research and development in the biotechnology industry. Polymerase chain reaction (PCR) is an important breakthrough in the biotechnology industry and is an integral part of the pharmaceutical and life science industries, for developing assays, test kits and solutions, and culture media. The rising use of these devices in the drug discovery is further fueling the market growth. For instance, in July 2021, Indian, Brazilian, and South African scientists are working together to repurpose, validate and synthesize lead compounds against main protease and RNA replicase, the enzyme that catalyzes the replication of RNA, of SARS-CoV-2. This process involves PCR for the amplification of the gene of interest and hence such initiatives boost the market growth in the country.

However, high cost of instruments and emergence of alternative technologies are the factors hindering the polymerase chain reaction market growth.

Scope of the Report

As per the scope of this report, polymerase chain reaction (PCR) is a technique that is used to amplify target DNA and generate thousands to millions of copies of a particular DNA segment. PCR techniques are used in clinical and research laboratories for a broad variety of applications, which include clinical diagnosis, criminal forensics, and biomedical research. The polymerase chain reaction market is segmented by product (instruments, reagents and consumables, and software), application (clinical diagnostics, life science research, industrial applications, and other applications), end-user (academic institutes, clinical diagnostics labs and hospitals, pharmaceutical and biotechnology industries, and other end-users), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product
Instruments
Standard PCR Systems
Digital PCR Systems
Real-time PCR Systems
Reagents and Consumables
Software
By Application
Clinical Diagnostics
Life Science Research and Industrial Applications
Other Applications
By End User
Academic Institutes
Clinical Diagnostics Labs and Hospitals
Pharmaceutical and Biotechnology Industries
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Clinical Diagnostics Segment is Expected to Witness a Significant Growth over the Forecast Period

By application, the clinical diagnostics segment is expected to witness significant growth over the forecast period.

PCR has become an integral part of clinical and diagnostic research and has transformed diagnostic medicine over years. There are numerous clinical diagnoses where PCR technology can be used. Thus, to overcome the clinical error rate, PCR is broadly used in the viral diagnosis of the disease. It reduces diagnosis time and has improved the specificity and accuracy of the result, thus driving market growth. According to an article, PCR past, present, and future, in August 2020, there are two main areas of PCR utilization in bioscience: high-throughput PCR systems and microfluidics-based PCR devices for point-of-care (POC) applications.

Also, the rising COVID-19 cases and spread of the disease in major countries have increased the demand for the diagnostic tests of the virus in the suspected population. This trend is primarily due to the low or non-availability of rapid or specific diagnostic tests for such diseases. Moreover, in May 2021, the Gene Lab- Clinical Diagnostic Lab by Clevergene opened a cutting-edge COVID-19 RT-PCR testing facility in Bengaluru. The ICMR approved lab has the capability of deploying automated RNA extraction and high-throughput RT-PCR to deliver up to 3000 tests in a single day.Therefore, pertaining to broad applications of PCR in clinical diagnostics, the segment is likely to register high growth during the forecast period.

Thus, owing to the aforementioned factors, the market is expected to register a significant growth during the forecast period.

Polymerase Chain Reaction Market: Number of People Living with HIV (in million), By Region, 2020

North America is Expected to Dominate the Market over the Forecast Period

Within North America, the United States has held a major share of the market. The major factors contributing to the market growth are the presence of many market players engaged in manufacturing, the increasing prevalence of genetic and chronic disorders, such as cancer, the aging population, the rising demand for precision and personalized medicine, and favorable government initiatives.

For instance, as the COVID-19 cases are increasing rapidly and the spread of the virus is very rapid, speeding up the transmission. The increasing count of suspects increases the number of diagnostic tests, boosting the market growth in the country. For instance, in April 2020, the United States Food and Drug Administration authorized the first diagnostic test with a home collection option for COVID-19. The FDA re-issued the emergency use authorization (EUA) for the Laboratory Corporation of America (LabCorp) COVID-19 RT-PCR Test to permit testing of samples self-collected by patients at home using LabCorp’s Pixel by LabCorp COVID-19 Test home collection kit.

Also, according to Cancer Statistics 2021 published in American Cancer Society Journal there is an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the United States, which will drive the market significantly.

Furthermore, the launch of new products based on PCR test will drive the market growth significantly. For instance, in September 2020, Roche received United States Food and Drug Administration (FDA) approval for the cobas HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas 6800/8800 Systems in the United States. The test will help healthcare professionals in confirming HIV diagnosis with single test and differentiate HIV-1 and HIV-2, an important distinction needed to identify appropriate treatment options. This test is based on PCR technology which will reduce the diagnosis time by one week, thus boosting the market.

Thus, in view of the factors mentioned above, the market is expected to witness significant growth in the region over the forecast period.

Polymerase Chain Reaction Market - Growth Rate by Region

Competitive Landscape

The market studied is moderately consolidated in nature, owing to the presence of a few major players. Some of the market players are Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., GE Healthcare, Merck KGaA, PerkinElmer Inc., Promega Corporation, Siemens Healthcare, and Thermo Fisher Scientific Inc. These major companies are found focusing on R&D to develop advanced technology products to gain a competitive edge. Companies are also found engaging in partnerships, mergers, and acquisitions, aiming to strengthen their product portfolios and manufacturing capacities and provide competitive differentiation.

Major Players

  1. Abbott Laboratories

  2. Agilent Technologies Inc.

  3. Thermo Fisher Scientific Inc.

  4. Siemens Healthineers

  5. BioMerieux SA

Polymerase Chain Reaction Market Concentration

Recent Developments

In June 2021, Thermo Fisher Scientific Inc. launched TaqPath, a new CE-IVD-marked fast PCR combo kit 2.0 to detect active SARS-CoV-2 infection.

In April 2020, Promega’s Corporation’s GoTaqProbe 1-Step RT-qPCR System is approved by Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Application in Clinical Diagnostics

      2. 4.2.2 Rising Demand for Personalized and Precision Medicines

      3. 4.2.3 Technological Advancements and Applications in Drug Development

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Instruments

      2. 4.3.2 Emergence of Alternative Technologies

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value -USD million)

    1. 5.1 By Product

      1. 5.1.1 Instruments

        1. 5.1.1.1 Standard PCR Systems

        2. 5.1.1.2 Digital PCR Systems

        3. 5.1.1.3 Real-time PCR Systems

      2. 5.1.2 Reagents and Consumables

      3. 5.1.3 Software

    2. 5.2 By Application

      1. 5.2.1 Clinical Diagnostics

      2. 5.2.2 Life Science Research and Industrial Applications

      3. 5.2.3 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Academic Institutes

      2. 5.3.2 Clinical Diagnostics Labs and Hospitals

      3. 5.3.3 Pharmaceutical and Biotechnology Industries

      4. 5.3.4 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Agilent Technologies Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 bioMerieux SA

      5. 6.1.5 Bio-Rad Laboratories Inc.

      6. 6.1.6 Merck KGaA

      7. 6.1.7 PerkinElmer Inc.

      8. 6.1.8 Promega Corporation

      9. 6.1.9 Siemens Healthcare

      10. 6.1.10 Thermo Fisher Scientific Inc.

      11. 6.1.11 Danaher Corporation

      12. 6.1.12 QIAGEN

      13. 6.1.13 QuantuMDx Group Ltd

      14. 6.1.14 Eppendorf

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Polymerase Chain Reaction Market market is studied from 2019 - 2027.

The Global Polymerase Chain Reaction Market is growing at a CAGR of >7.8% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, BioMerieux SA are the major companies operating in Global Polymerase Chain Reaction Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!